Skip to main content
. 2024 Jan 13;11(2):923–936. doi: 10.1002/ehf2.14637

Table 3.

Outcomes

Total NS NSML CS CFCS Noonan‐like P value
Death, n (%) 21 (14.1) 13 (11.7) 1 (8.3) 1 (16.7) 1 (16.7) 3 (27.3) 0.083
SCD, n (%) 1 (4.8) 1 (7.7)
CCF, n (%) 2 (9.5) 1 (7.7) 1 (8.3)
Other CVS, n (%) 1 (4.8) 1 (7.7)
Other, n (%) 4 (19.1) 2 (15.4) 1 (100) 1 (33.3)
Unknown, n (%) 12 (57.1) 7 (53.9) 1 (100) 2 (66.7)
Age at death (months), median (25–75th centile) 24.1 (5.6–175.9) 25.9 (5.6–175.9) 1.7 12.9 191.1 23.1 (12–73.8) 0.469
Myectomy, n (%) 14 (9.4) 13 (11.7) 1 (8.3) 0.886
ICD implantation, n (%) 7 (4.7) 7 (6.3) 0.653
CCF admission, n (%) 10 (6.7) 9 (8.1) 1 (8.3) 0.715
Heart transplant, n (%) 3 (2) 3 (2.7) 0.909
NSVT, n (%) 5 (3.4) 3 (3) 1 (8.3) 1 (33.3) 0.674
SCD or equivalent event, n (%) 12 (8.1) 9 (8.1) 1 (8.3) 2 (18.2) 0.775

CCF, congestive cardiac failure; CFCS, cardiofaciocutaneous syndrome; CS, Costello syndrome; CVS, cardiovascular; ICD, implantable cardiac defibrillator; n, number of patients; NS, Noonan syndrome; NSML, Noonan syndrome with multiple lentigines; NSVT, non‐sustained ventricular tachycardia; SCD, sudden cardiac death.Bold numbers represent statistically‐significant p values